Li Yu - 18 May 2021 Form 3 Insider Report for OncoCyte Corp (OCX)

Role
VP Cntrllr/Prncpl Acctng Offcr
Signature
/s/ Li Yu
Issuer symbol
OCX
Transactions as of
18 May 2021
Transactions value $
$0
Form type
3
Filing time
24 May 2021, 19:19:40 UTC
Next filing
14 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCX Restricted Stock Units 18 May 2021 Common Stock 25K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant.
F2 Grant of restricted stock units under the OncoCyte 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock.